ReviewFrontiers in neuroscience2025
Oligodendrocytes and myelination: pioneering new frontiers in cognitive neuroscience.
Review in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Emodin Suppresses the RAGE/ROCK1 Pathway to Modulate the Oligodendrocyte Lineage and Ameliorate Demyelination in Vascular Dementia Rats.CNS neuroscience & therapeutics · 2026Article
- Beyond the neuron: the role of glial cells in viral neuropathogenesis.Journal of virology · 2026Review
- Article
- Alterations in glutamatergic and GABAergic signaling in ketamine-induced neurotoxicity: mangiferin mitigates neurochemical, oxidative, and astrocytic dysregulation in the rat temporal-frontal cortex.Behavioral and brain functions : BBF · 2026Article
- Integrative genomic and spatial transcriptomic analysis elucidates the oligodendrocyte-mediated etiology of epileptic cortical thinning.Epilepsia open · 2026Article
- Detecting early brain susceptibility changes before demyelination in cuprizone mouse model using quantitative susceptibility mapping (QSM).NeuroImage · 2026Article
- Protein Modifications and Quality Control System: Target for Alzheimer's Disease Therapy.International journal of molecular sciences · 2026Review
- Conserved Pathways, Divergent Outcomes: A Cross-Species Genomic Perspective on the Cancer-Neurodegeneration Paradox.International journal of molecular sciences · 2026Review
- Mapping the Ischemic Continuum: Dynamic Multi-Omic Biomarker and AI for Personalized Stroke Care.International journal of molecular sciences · 2026Review
- A prelimbic molecular clock of protein synthesis for memory persistence.bioRxiv : the preprint server for biology · 2026Article
- The role of sensory experience in the maturation of prefrontal cortical circuits.Frontiers in neuroscience · 2026Review
- Histone demethylase KDM6B promotes postnatal oligodendrocyte maturation and cortical myelination.Frontiers in cellular neuroscience · 2026Article
- Exploiting glial cell functions for neurodegeneration therapy.Neuroprotection (Chichester, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There has been a growing interest in the role of oligodendrocytes (OLs) and the myelin sheaths they form around axons in cognitive function. Historically, OLs were primarily considered to be involved in axonal insulation and signal transmission within the central nervous system (CNS). However, an increasing body of research indicates that OLs and myelination are integral to neural circuit formation, the regulation of plasticity, and higher-order cognitive functions. Developmental and functional abnormalities in OLs, as well as deficits in myelination, are pathologically associated with diseases characterized by clinical cognitive dysfunction. These abnormalities have significant implications for the development of diagnostic and therapeutic strategies for neurological disorders and for the advancement and innovation of treatment methodologies. Investigations into the impact of OLs and myelination on cognitive function offer a novel perspective for understanding the development, plasticity, and pathophysiological mechanisms of the nervous system. Future research endeavors are anticipated to elucidate the complexities of OLs and myelination, thereby offering renewed prospects for the diagnosis and treatment of neurological disorders. This review provides a systematic examination of contemporary research concerning OLs and myelination, covering fundamental mechanisms, their roles in cognitive function, recent clinical advancements, emerging therapeutic strategies, ongoing scientific debates, key challenges, and future directions. By incorporating multidisciplinary perspectives, this synthesis seeks to establish a comprehensive framework that will guide subsequent investigations in this domain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.